Croatia vs Cuba: Cause of death, by non-communicable diseases, ages 5-14, female
Croatia
67.2%
in 2021
Cuba
67.7%
in 2021
Croatia rank
18th
Cuba rank
17th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Croatia
- Cuba
How they compare
Cuba currently reports 67.7% against 67.2% in Croatia, a difference of 0.5%.
Across all 6 years both countries report, Cuba has been ahead every year.
Croatia ranks 18th and Cuba ranks 17th of 184 countries.
Cuba has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.2% | 51.4% | 0.2% | Cuba |
| 2010s | 57.5% | 68.2% | 10.7% | Cuba |
| 2020s | 63.0% | 72.6% | 9.6% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Croatia or Cuba?
- Cuba, at 67.7% against 67.2% in Croatia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Croatia and Cuba?
- 0.5%, with Cuba ahead.
- How many years of comparable data are there for Croatia and Cuba?
- 6 years are reported by both, from 2000 to 2021.
- How do Croatia and Cuba rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Croatia ranks 18th and Cuba ranks 17th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.